Skip to main content
# Title Research Member Research Year
111 Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. Dr. Yasser Gaber Ali Abdelhafez 2015
112 A Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation
...
Dr. Alia Mohamed Ali Attia 2015
113 Intravenous Fluorouracil versus Oral Capecitabine: Postoperative Chemoradiation for Gastric Cancer Dr. Shaimaa / Elsayyed Youssef / Ahmed 2015
114 Prognostic Value of KRAS Mutations in Codons 12 and 13 in South Egyptian Colorectal Cancer Patients Dr. Alia Mohamed Ali Attia 2015
115 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
116 The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma Dr. Yasser Gaber Ali Abdelhafez 2015
117 Intravenous Fluorouracil versus Oral Capecitabine: Postoperative Chemoradiation for Gastric Cancer Prof. Hamza Abbas Hamza Mohammed 2015
118 Influence of patient and breast setup errors on dose distribution of tangential IMRT (t-IMRT) and VMAT deliveries in breast cancer: a search for optimal IGRT matching strategy for patients with average or large breast sizes Dr. Moamen Mohamed Omran Moustafa Aly 2015
119 Laparoscopy assisted distal gastrectomy for T1 to T2 stage gastric cancer: a pilot study of three ports technique Prof. Hamza Abbas Hamza Mohammed 2015
120 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Prof. Mohamed Ibrahim Mohamed El-Sayed 2015